(+)-Epicatechin and Cardiometabolic Endpoints

stack of textbooks representing peer-reviewed studies about (-)-epicatechin and mitochondria research

This pilot study evaluated the pharmacokinetics, initial safety, and early cardiometabolic effects of (+)-epicatechin in humans and preclinical models, suggesting a favorable early profile.

Triglyceride/HDL Ratio and Cardiometabolic Profile

stack of textbooks representing peer-reviewed studies about (-)-epicatechin and mitochondria research

Randomized, double-blind placebo-controlled trial in people with hypertriglyceridemia. The study reported preliminary favorable effects on glycemic homeostasis, lipid profile, and systemic inflammation, with parallel in vitro findings suggesting pathway-specific rather than generic antioxidant effects.